Literature DB >> 1294638

The effect of loperamide on anorectal function in normal healthy men.

F Musial1, P Enck, K T Kalveram, J F Erckenbrecht.   

Abstract

Loperamide improves anorectal functioning in patients with diarrhea and incontinence. Loperamide reduces sensitivity of the recto-anal inhibitory reflex and increases internal anal sphincter tone. Additionally, it has an effect on rectal compliance in incontinent patients with diarrhea. We studied the effect of loperamide versus placebo at different distances from the anal verge in 18 healthy male volunteers, using standard anorectal manometry was a double-blind, two-factorial design. We found that the recto-anal inhibitory reflex is most pronounced when stimulated in regions close to the anal canal and that distention stimuli are also perceived best in that region. Both effects are counteracted by loperamide. We found no effect on internal sphincter tone or rectal compliance. These results imply a gradient of sensitivity for rectal perception and the recto-anal inhibitory reflex in healthy volunteers. Loperamide action on both mechanisms suggests a common mediator for both effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294638     DOI: 10.1097/00004836-199212000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  18 in total

Review 1.  Evolving paradigms in the treatment of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

Review 2.  New therapies for functional bowel diseases.

Authors:  B Coulie; M Camilleri
Journal:  Curr Gastroenterol Rep       Date:  2000-10

Review 3.  Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Authors:  Adam D Farmer; Asbjørn M Drewes; Giuseppe Chiarioni; Roberto De Giorgio; Tony O'Brien; Bart Morlion; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-12-14       Impact factor: 4.623

Review 4.  Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

Authors:  Spencer Dorn; Anthony Lembo; Filippo Cremonini
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

Review 5.  Opioid-induced constipation: advances and clinical guidance.

Authors:  Alfred D Nelson; Michael Camilleri
Journal:  Ther Adv Chronic Dis       Date:  2016-01-25       Impact factor: 5.091

Review 6.  Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.

Authors:  Michael Camilleri; Anthony Lembo; David A Katzka
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-19       Impact factor: 11.382

Review 7.  Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities.

Authors:  Alfred D Nelson; Michael Camilleri
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

8.  Diabetics on Narcotics Are Less Likely to Achieve Excellent Bowel Preparation Than Are Patients with Either Condition.

Authors:  Mohammad F Madhoun; Hussein Bitar; Owais Bhatti; Hassaan Zia; Pratyusha Parava; Muhammad H Bashir
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

9.  Loperamide improves anal sphincter function and continence after restorative proctocolectomy.

Authors:  T Hallgren; S Fasth; D S Delbro; S Nordgren; T Oresland; L Hultén
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

Review 10.  Management of patients with faecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Jonas Worsoe; Lilli Lundby; Peter Christensen; Klaus Krogh
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.